Robert E. Hoffman - 08 Nov 2021 Form 4 Insider Report for Kintara Therapeutics, Inc. (HURA)

Role
President and CEO, Director
Signature
/s/ Robert Hoffman
Issuer symbol
HURA
Transactions as of
08 Nov 2021
Net transactions value
$0
Form type
4
Filing time
10 Nov 2021, 15:18:07 UTC
Previous filing
22 Sep 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +3,519,170 $0.000000 3,519,170 08 Nov 2021 Common Stock 3,519,170 $0.9600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to the reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment, the shares subject to the option shall vest as follows: 25% of the shares subject to the option shall vest on November 8, 2022, and the remainder shall vest in equal monthly installments over the following thirty-six (36) months.

Remarks:

Exhibit 24 - Power of Attorney